Global Drug Repurposing Market Professional Survey Report 2019

Drug repurposing or re-profiling has been the hallmark to bring strong business growth and the trend is being followed by majority of the pharmaceutical and biopharmaceutical companies. Among all biologics approved in the U.S. during 2007-2009, 30-40% of them were the drugs repurposed or repositioned. National Institute of Health (NIH), U.S. Department of Health defines drug repurposing as discovering new uses for approved drugs to provide the quickest possible transition from bench to bedside. Drug repurposing opens up various opportunities to answer current unmet medical needs to come up with cost-effective solutions to expensive drug development process. Repurposing or re-profiling of drugs which are suspended due to lack of efficacy or specificity can be a good start over for further development for new indication. Finding new indications for already studied drugs can benefit patients by getting quick access to new treatment choices and also to developer by saving time and money while maintaining its original IP protection. For many expensive indications such as cancer, scrutinizing for anti-cancer activity among dozens of off-patent drugs that have already established their safety is a powerful method opted by majority of the big pharma companies. However, repurposing is not a new strategy and there are bunch of drugs which are repositioned or repurposed, some of them are Raloxifene (approved for treatment of osteoporosis in 2007, originally indicated for breast cancer treatment), Thalidomide (repositioned for use in treatment of leprosy and multiple myeloma in 2006), Rapamycin (repurposed in 1999 for prevention of organ transplant rejection), Sildenafil (originally approved for erectile dysfunction and recently got approved for treatment of angina) and many others.
Requirement of low investment of time and money in the drug development is the prime advantage of drug repurposing and majority of the drugs in pipeline of major pharmaceutical companies are thus adopt this method. Some of the factors accelerating the drug repurposing activities include sunk research cost, ready availably of bioavailability, pharmacology, toxicity profile & pharmacokinetics data, well established manufacturing protocol etc.; which are expected to drive the global drug repurposing market. There are thousands of failed molecules shelved into the drug libraries, which hold vast potential to reposition. Whereas, limited access chemical structure data of drug molecules, lack of funding etc. are some of the factors limiting the growth of global drug repurposing market.

The global Drug Repurposing market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Drug Repurposing volume and value at global level, regional level and company level. From a global perspective, this report represents overall Drug Repurposing market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Drug Repurposing in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Drug Repurposing manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Astellas Pharma
Biovista
Novartis
AbbVie
Pfizer
Allergan
NuMedii
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Oncology
CNS Diseases
Neurodegenerative Diseases
Others

Segment by Application
Hospitals
Ambulatory Surgical Centers
Others

Table of Contents

Executive Summary
1 Industry Overview of Drug Repurposing
1.1 Definition of Drug Repurposing
1.2 Drug Repurposing Segment by Type
1.2.1 Global Drug Repurposing Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Oncology
1.2.3 CNS Diseases
1.2.4 Neurodegenerative Diseases
1.2.5 Others
1.3 Drug Repurposing Segment by Applications
1.3.1 Global Drug Repurposing Consumption Comparison by Applications (2014-2025)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Global Drug Repurposing Overall Market
1.4.1 Global Drug Repurposing Revenue (2014-2025)
1.4.2 Global Drug Repurposing Production (2014-2025)
1.4.3 North America Drug Repurposing Status and Prospect (2014-2025)
1.4.4 Europe Drug Repurposing Status and Prospect (2014-2025)
1.4.5 China Drug Repurposing Status and Prospect (2014-2025)
1.4.6 Japan Drug Repurposing Status and Prospect (2014-2025)
1.4.7 Southeast Asia Drug Repurposing Status and Prospect (2014-2025)
1.4.8 India Drug Repurposing Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Drug Repurposing
2.3 Manufacturing Process Analysis of Drug Repurposing
2.4 Industry Chain Structure of Drug Repurposing

3 Development and Manufacturing Plants Analysis of Drug Repurposing
3.1 Capacity and Commercial Production Date
3.2 Global Drug Repurposing Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Drug Repurposing
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Drug Repurposing Production and Capacity Analysis
4.2 Drug Repurposing Revenue Analysis
4.3 Drug Repurposing Price Analysis
4.4 Market Concentration Degree

5 Drug Repurposing Regional Market Analysis
5.1 Drug Repurposing Production by Regions
5.1.1 Global Drug Repurposing Production by Regions
5.1.2 Global Drug Repurposing Revenue by Regions
5.2 Drug Repurposing Consumption by Regions
5.3 North America Drug Repurposing Market Analysis
5.3.1 North America Drug Repurposing Production
5.3.2 North America Drug Repurposing Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Drug Repurposing Import and Export
5.4 Europe Drug Repurposing Market Analysis
5.4.1 Europe Drug Repurposing Production
5.4.2 Europe Drug Repurposing Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Drug Repurposing Import and Export
5.5 China Drug Repurposing Market Analysis
5.5.1 China Drug Repurposing Production
5.5.2 China Drug Repurposing Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Drug Repurposing Import and Export
5.6 Japan Drug Repurposing Market Analysis
5.6.1 Japan Drug Repurposing Production
5.6.2 Japan Drug Repurposing Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Drug Repurposing Import and Export
5.7 Southeast Asia Drug Repurposing Market Analysis
5.7.1 Southeast Asia Drug Repurposing Production
5.7.2 Southeast Asia Drug Repurposing Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Drug Repurposing Import and Export
5.8 India Drug Repurposing Market Analysis
5.8.1 India Drug Repurposing Production
5.8.2 India Drug Repurposing Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Drug Repurposing Import and Export

6 Drug Repurposing Segment Market Analysis (by Type)
6.1 Global Drug Repurposing Production by Type
6.2 Global Drug Repurposing Revenue by Type
6.3 Drug Repurposing Price by Type

7 Drug Repurposing Segment Market Analysis (by Application)
7.1 Global Drug Repurposing Consumption by Application
7.2 Global Drug Repurposing Consumption Market Share by Application (2014-2019)

8 Drug Repurposing Major Manufacturers Analysis
8.1 Astellas Pharma
8.1.1 Astellas Pharma Drug Repurposing Production Sites and Area Served
8.1.2 Astellas Pharma Product Introduction, Application and Specification
8.1.3 Astellas Pharma Drug Repurposing Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Biovista
8.2.1 Biovista Drug Repurposing Production Sites and Area Served
8.2.2 Biovista Product Introduction, Application and Specification
8.2.3 Biovista Drug Repurposing Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Novartis
8.3.1 Novartis Drug Repurposing Production Sites and Area Served
8.3.2 Novartis Product Introduction, Application and Specification
8.3.3 Novartis Drug Repurposing Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 AbbVie
8.4.1 AbbVie Drug Repurposing Production Sites and Area Served
8.4.2 AbbVie Product Introduction, Application and Specification
8.4.3 AbbVie Drug Repurposing Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Pfizer
8.5.1 Pfizer Drug Repurposing Production Sites and Area Served
8.5.2 Pfizer Product Introduction, Application and Specification
8.5.3 Pfizer Drug Repurposing Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Allergan
8.6.1 Allergan Drug Repurposing Production Sites and Area Served
8.6.2 Allergan Product Introduction, Application and Specification
8.6.3 Allergan Drug Repurposing Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 NuMedii
8.7.1 NuMedii Drug Repurposing Production Sites and Area Served
8.7.2 NuMedii Product Introduction, Application and Specification
8.7.3 NuMedii Drug Repurposing Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served

9 Development Trend of Analysis of Drug Repurposing Market
9.1 Global Drug Repurposing Market Trend Analysis
9.1.1 Global Drug Repurposing Market Size (Volume and Value) Forecast 2019-2025
9.2 Drug Repurposing Regional Market Trend
9.2.1 North America Drug Repurposing Forecast 2019-2025
9.2.2 Europe Drug Repurposing Forecast 2019-2025
9.2.3 China Drug Repurposing Forecast 2019-2025
9.2.4 Japan Drug Repurposing Forecast 2019-2025
9.2.5 Southeast Asia Drug Repurposing Forecast 2019-2025
9.2.6 India Drug Repurposing Forecast 2019-2025
9.3 Drug Repurposing Market Trend (Product Type)
9.4 Drug Repurposing Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Drug Repurposing Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Drug Repurposing
Table Global Drug Repurposing Production (K MT) Growth Rate Comparison by Types (2014-2025)
Figure Global Drug Repurposing Production Market Share by Types in 2018
Figure Oncology Product Picture
Figure CNS Diseases Product Picture
Figure Neurodegenerative Diseases Product Picture
Figure Others Product Picture
Table Global Drug Repurposing Consumption (K MT) Comparison by Applications (2014-2025)
Figure Global Drug Repurposing Consumption Market Share by Applications in 2018
Figure Hospitals
Figure Ambulatory Surgical Centers
Figure Others
Figure Global Drug Repurposing Revenue (Million USD) (2014-2025)
Figure Global Drug Repurposing Production (K MT) (2014-2025)
Figure North America Drug Repurposing Market Size (Million USD) (2014-2025)
Figure Europe Drug Repurposing Market Size (Million USD) (2014-2025)
Figure China Drug Repurposing Market Size (Million USD) (2014-2025)
Figure Japan Drug Repurposing Market Size (Million USD) (2014-2025)
Figure Southeast Asia Drug Repurposing Market Size (Million USD) (2014-2025)
Figure India Drug Repurposing Market Size (Million USD) (2014-2025)
Table Drug Repurposing Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Drug Repurposing in 2018
Figure Manufacturing Process Analysis of Drug Repurposing
Figure Industry Chain Structure of Drug Repurposing
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Drug Repurposing Manufacturing Plants Distribution
Table Drug Repurposing Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Drug Repurposing Capacity (K MT) of Major Manufacturers (2014-2019)
Table Drug Repurposing Production (K MT) of Major Manufacturers (2014-2019)
Table Drug Repurposing Production Market Share of Major Manufacturers (2014-2019)
Figure Drug Repurposing Production Share by Manufacturers in 2018
Table Drug Repurposing Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Drug Repurposing Revenue Market Share of Major Manufacturers (2014-2019)
Figure Drug Repurposing Revenue Share by Manufacturers in 2018
Table Drug Repurposing Average Price (USD/MT) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Drug Repurposing Production by Regions 2014-2019 (K MT)
Table Global Drug Repurposing Production Market Share by Regions 2014-2019
Figure Global Drug Repurposing Production Market Share by Regions in 2018
Table Global Drug Repurposing Revenue by Regions 2014-2019 (Million USD)
Table Global Drug Repurposing Revenue Market Share by Regions 2014-2019
Figure Global Drug Repurposing Revenue Market Share by Regions in 2018
Table Global Drug Repurposing Consumption by Regions 2014-2019 (K MT)
Table Global Drug Repurposing Consumption Market Share by Regions 2014-2019
Figure North America Drug Repurposing Production Growth Rate 2014-2019 (K MT)
Figure North America Drug Repurposing Revenue Growth Rate 2014-2019 (Million USD)
Table North America Drug Repurposing Production, Consumption Import and Export (K MT)
Figure Europe Drug Repurposing Production Growth Rate 2014-2019 (K MT)
Figure Europe Drug Repurposing Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Drug Repurposing Production, Consumption Import and Export (K MT)
Figure China Drug Repurposing Production Growth Rate 2014-2019 (K MT)
Figure China Drug Repurposing Revenue Growth Rate 2014-2019 (Million USD)
Table China Drug Repurposing Production, Consumption Import and Export (K MT)
Figure Japan Drug Repurposing Production Growth Rate 2014-2019 (K MT)
Figure Japan Drug Repurposing Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Drug Repurposing Production, Consumption Import and Export (K MT)
Figure Southeast Asia Drug Repurposing Production Growth Rate 2014-2019 (K MT)
Figure Southeast Asia Drug Repurposing Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Drug Repurposing Production, Consumption Import and Export (K MT)
Figure India Drug Repurposing Production Growth Rate 2014-2019 (K MT)
Figure India Drug Repurposing Revenue Growth Rate 2014-2019 (Million USD)
Table India Drug Repurposing Production, Consumption Import and Export (K MT)
Figure Global Consumption Drug Repurposing Market Share by Application (2014-2019)
Figure Global Value (Consumption) Drug Repurposing Market Share by Application (2014-2019)
Table Astellas Pharma Drug Repurposing Production Sites and Area Served
Table Astellas Pharma Drug Repurposing Product Introduction, Application and Specification
Table Astellas Pharma Drug Repurposing Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Astellas Pharma Drug Repurposing Production Growth Rate (2014-2019)
Table Astellas Pharma Drug Repurposing Production Market Share (2014-2019)
Figure Astellas Pharma Drug Repurposing Revenue Market Share (2014-2019)
Table Astellas Pharma Drug Repurposing Main Business and Markets Served
Table Biovista Drug Repurposing Production Sites and Area Served
Table Biovista Drug Repurposing Product Introduction, Application and Specification
Table Biovista Drug Repurposing Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Biovista Drug Repurposing Production Growth Rate (2014-2019)
Table Biovista Drug Repurposing Production Market Share (2014-2019)
Figure Biovista Drug Repurposing Revenue Market Share (2014-2019)
Table Biovista Drug Repurposing Main Business and Markets Served
Table Novartis Drug Repurposing Production Sites and Area Served
Table Novartis Drug Repurposing Product Introduction, Application and Specification
Table Novartis Drug Repurposing Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Novartis Drug Repurposing Production Growth Rate (2014-2019)
Table Novartis Drug Repurposing Production Market Share (2014-2019)
Figure Novartis Drug Repurposing Revenue Market Share (2014-2019)
Table Novartis Drug Repurposing Main Business and Markets Served
Table AbbVie Drug Repurposing Production Sites and Area Served
Table AbbVie Drug Repurposing Product Introduction, Application and Specification
Table AbbVie Drug Repurposing Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table AbbVie Drug Repurposing Production Growth Rate (2014-2019)
Table AbbVie Drug Repurposing Production Market Share (2014-2019)
Figure AbbVie Drug Repurposing Revenue Market Share (2014-2019)
Table AbbVie Drug Repurposing Main Business and Markets Served
Table Pfizer Drug Repurposing Production Sites and Area Served
Table Pfizer Drug Repurposing Product Introduction, Application and Specification
Table Pfizer Drug Repurposing Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Pfizer Drug Repurposing Production Growth Rate (2014-2019)
Table Pfizer Drug Repurposing Production Market Share (2014-2019)
Figure Pfizer Drug Repurposing Revenue Market Share (2014-2019)
Table Pfizer Drug Repurposing Main Business and Markets Served
Table Allergan Drug Repurposing Production Sites and Area Served
Table Allergan Drug Repurposing Product Introduction, Application and Specification
Table Allergan Drug Repurposing Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Allergan Drug Repurposing Production Growth Rate (2014-2019)
Table Allergan Drug Repurposing Production Market Share (2014-2019)
Figure Allergan Drug Repurposing Revenue Market Share (2014-2019)
Table Allergan Drug Repurposing Main Business and Markets Served
Table NuMedii Drug Repurposing Production Sites and Area Served
Table NuMedii Drug Repurposing Product Introduction, Application and Specification
Table NuMedii Drug Repurposing Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table NuMedii Drug Repurposing Production Growth Rate (2014-2019)
Table NuMedii Drug Repurposing Production Market Share (2014-2019)
Figure NuMedii Drug Repurposing Revenue Market Share (2014-2019)
Table NuMedii Drug Repurposing Main Business and Markets Served
Figure Global Drug Repurposing Production (K MT) Growth Rate Forecast 2019-2025
Figure Global Drug Repurposing Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Drug Repurposing Sales Price (USD/MT) Forecast 2019-2025
Figure North America Drug Repurposing Production Growth Rate Forecast 2019-2025 (K MT)
Figure North America Drug Repurposing Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Drug Repurposing Production Growth Rate Forecast 2019-2025 (K MT)
Figure Europe Drug Repurposing Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Drug Repurposing Production Growth Rate Forecast 2019-2025 (K MT)
Figure China Drug Repurposing Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Drug Repurposing Production Growth Rate Forecast 2019-2025 (K MT)
Figure Japan Drug Repurposing Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Drug Repurposing Production Growth Rate Forecast 2019-2025 (K MT)
Figure Southeast Asia Drug Repurposing Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Drug Repurposing Production Growth Rate Forecast 2019-2025 (K MT)
Figure India Drug Repurposing Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K MT) of Drug Repurposing by Type (2019-2025)
Table Global Consumption (K MT) of Drug Repurposing by Application (2019-2025)
Table Drug Repurposing Distributors List
Table Drug Repurposing Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Choose License Type